APIM THERAPEUTICS AS has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in Republic of Korea, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are GENERVON BIOPHARMACEUTICALS LLC, ALIZE PHARMA SAS and FIBREX MEDICAL RES & DEV GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Hungary | 1 | |
#9 | Israel | 1 | |
#10 | Japan | 1 | |
#11 | Mexico | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Medical preparations | |
#3 | Enzymes | |
#4 | Peptides | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Otterlei Marit | 12 |
#2 | Aas Per Arne | 11 |
#3 | Feyzi Emadoldin | 11 |
#4 | Marit Otterlei | 3 |
#5 | Emadoldin Feyzi | 2 |
#6 | Per Arne Aas | 2 |
#7 | Arne Aas Per | 1 |
#8 | Feyzi Ermadoldin | 1 |
#9 | Ermadoldin Feyzi | 1 |
#10 | Aas Per | 1 |